Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review

K Kawai, MA O'Brien, MG Goveia, TC Mast… - Vaccine, 2012 - Elsevier
BACKGROUND: Rotavirus is the leading cause of severe diarrhea in children worldwide.
We systematically reviewed the burden of rotavirus gastroenteritis (RVGE) and distribution of …

Reviewing the evidence on breast milk composition and immunological outcomes

A Boix-Amorós, MC Collado, B Van't Land… - Nutrition …, 2019 - academic.oup.com
A large number of biologically active components have been found in human milk (HM), and
in both human and animal models, studies have provided some evidence suggesting that …

A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy

M Patel, RI Glass, B Jiang, M Santosham… - The Journal of …, 2013 - academic.oup.com
Background. Identifying an immunological correlate of protection for rotavirus vaccines
(Rotarix [RV1] and RotaTeq [RV5]) would substantially facilitate testing of interventions for …

[HTML][HTML] Prevention of rotavirus gastroenteritis among infants and children

UD Parashar, JP Alexander, RI Glass… - … of the Advisory …, 2006 - cdc.gov
In February 2006, a live, oral, human-bovine reassortant rotavirus vaccine (RotaTeq®) was
licensed for use among US infants. The Advisory Committee on Immunization Practices …

Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004–2005: the REVEAL study

P Van Damme, C Giaquinto, F Huet… - The Journal of …, 2007 - academic.oup.com
Background. Rotavirus is recognized as a significant cause of pediatric gastroenteritis
worldwide. Comprehensive data on the burden of rotavirus disease in Europe were lacking …

Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq

M Zeller, JT Patton, E Heylen, S De Coster… - Journal of clinical …, 2012 - Am Soc Microbiol
Two live-attenuated rotavirus group A (RVA) vaccines, Rotarix (G1P [8]) and RotaTeq (G1-
G4, P [8]), have been successfully introduced in many countries worldwide, including …

Meta‐analysis: Lactobacillus GG for treating acute diarrhoea in children

H Szajewska, A Skórka, M Ruszczyński… - Alimentary …, 2007 - Wiley Online Library
Aim To review evidence for the effectiveness of Lactobacillus GG (LGG) in treating acute
infectious diarrhoea in children. Methods The following electronic databases were searched …

Safety and immunogenicity of a parenteral P2-VP8-P [8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo …

MJ Groome, A Koen, A Fix, N Page, L Jose… - The Lancet Infectious …, 2017 - thelancet.com
Background Efficacy of live oral rotavirus vaccines is reduced in low-income compared with
high-income settings. Parenteral non-replicating rotavirus vaccines might offer benefits over …

Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua

M Patel, C Pedreira, LH De Oliveira, J Tate, M Orozco… - Jama, 2009 - jamanetwork.com
Context Pentavalent rotavirus vaccine (RV5), a live, oral attenuated vaccine, prevented 98%
of severe rotavirus diarrhea in a trial conducted mainly in Finland and the United States …

The impact of rotavirus vaccines on genotype diversity: a comprehensive analysis of 2 decades of Australian surveillance data

S Roczo-Farkas, CD Kirkwood, D Cowley… - The Journal of …, 2018 - academic.oup.com
Background Introduction of rotavirus vaccines into national immunization programs (NIPs)
could result in strain selection due to vaccine-induced selective pressure. This study …